Second counterpoint: animal tumor models and their relevance to human tumor immunology

Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.

Cancer research·1992

The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.

Cancer research·1992

Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role.

Journal of immunology (Baltimore, Md. : 1950)·1992

Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.

International journal of cancer·1992

Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.

Journal of immunology (Baltimore, Md. : 1950)·1992

Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration.

Natural immunity·1992

Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.

Journal of biological response modifiers·1990

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.

Journal of biological response modifiers·1990

Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.

Journal of biological response modifiers·1990

Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.

Journal of biological response modifiers·1990

Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma.

Journal of biological response modifiers·1990

Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects.

Journal of biological response modifiers·1990

CMTM6 maintains B cell-intrinsic membrane CD40 stability to regulate anti-tumor immunity.

Acta pharmaceutica Sinica. B·2026

Thyroglobulin antibody in differentiated thyroid cancer: international laboratory practice survey and the case for a dual-threshold model.

Clinical chemistry and laboratory medicine·2026

Imiquimod triggers TLR7-independent apoptosis but TLR7-dependent activation in murine CD4+ T cells.

Biochemical and biophysical research communications·2026

Epidemiology and Survival Determinants of Monomorphic Epitheliotropic T-Cell Lymphoma: A Pooled Patient-Level Dataset Analysis.

Hematological oncology·2026

Imaging and Quantification of Immune Cells in the Tumor Microenvironment Using a Zebrafish Model of Neuroblastoma.

Journal of visualized experiments : JoVE·2026

T cell exhaustion in parasitic infections.

Frontiers in immunology·2026

Related Experiment Videos

Second counterpoint: animal tumor models and their relevance to human tumor immunology

Related Concept Videos

Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.

The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.

Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role.

Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.

Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.

Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration.

Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.

Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.

Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.

Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma.

Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects.

CMTM6 maintains B cell-intrinsic membrane CD40 stability to regulate anti-tumor immunity.

Thyroglobulin antibody in differentiated thyroid cancer: international laboratory practice survey and the case for a dual-threshold model.

Imiquimod triggers TLR7-independent apoptosis but TLR7-dependent activation in murine CD4+ T cells.

Epidemiology and Survival Determinants of Monomorphic Epitheliotropic T-Cell Lymphoma: A Pooled Patient-Level Dataset Analysis.

Imaging and Quantification of Immune Cells in the Tumor Microenvironment Using a Zebrafish Model of Neuroblastoma.

T cell exhaustion in parasitic infections.

Related Experiment Videos

Second counterpoint: animal tumor models and their relevance to human tumor immunology

Related Concept Videos

Related Articles